SciELO - Scientific Electronic Library Online

 
vol.39 número6Duração da consulta: fatores influenciadores e perspetivas de médicos e utentes - um estudo transversalAbordagem da esteatose hepática não alcoólica nos cuidados de saúde primários índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Portuguesa de Medicina Geral e Familiar

versão impressa ISSN 2182-5173

Resumo

OLIVEIRA, Mariana B.; CAMPOS, Catarina; LASCASAS, Joana  e  SILVA, Vera Ribeiro da. Evaluation of deprescribing in primary care, from a medical perspective. Rev Port Med Geral Fam [online]. 2023, vol.39, n.6, pp.563-581.  Epub 31-Dez-2023. ISSN 2182-5173.  https://doi.org/10.32385/rpmgf.v39i6.13760.

Introduction:

Therapeutic deprescribing consists of identifying and proposing the withdrawal medicines whose harms outweigh their benefits, and this complex management is usually part of the family physician (FP) role.

Objectives:

Determine FPs’ self-perceptions of their deprescribing practices, as well as barriers and facilitators. A secondary aim was to raise FP awareness of deprescribing.

Methods: Observational and descriptive study in which FPs and 3rd and 4th-year family medicine residents in a northern region of Portugal completed an online survey. The study was approved by the ethics committee, and statistical analysis was performed in Microsoft Excel®.

Results:

There were 63 responses, of which 68.3% were female, with a mean age of 42.8 years. In the sample, 81% were specialists and 57.1% and 14.3% had training in palliative care and geriatrics respectively. Regarding deprescribing, 98% frequently saw patients with multimorbidity and 97% with polypharmacy. However, 49.2% of respondents reported deprescribing only occasionally. The most commonly deprescribed drugs were non-steroidal anti-inflammatory drugs, statins, and bisphosphonates. Patient characteristics considered very important for deprescribing were: quality of life (79.4%), life expectancy (71.4%), cognitive orientation (60%), and physical dependence (49.2%). The risks (65.1%) and benefits (52.4%) of the drug and the existence of guidelines (46%) were considered the most important factors (not related to the patient) in the decision to deprescribe. The most frequently observed barrier was limited time for therapeutic review (41.3%), while poor adherence was occasionally recognized as a facilitator by the majority (69.8%).

Conclusion:

Patients with deprescribing criteria are often recognized by the FP, but there is still a lack of proactivity in this practice. The existence of guidelines was considered a very important factor and limited time was a frequent barrier. Therefore, creating guidelines and specific consultations could be strategies for improvement.

Palavras-chave : Deprescribing; Polypharmacy; Multimorbidity; Primary health care; Family physician.

        · resumo em Português     · texto em Português     · Português ( pdf )